TETW 2012 - 13th Tetrahedron Symposium (Asia) - Challenges in Bioorganic & Organic Medicinal Chemistry

We welcome participants to the 13th Tetrahedron Symposium (Asia), which will focus on the many crucial contributions that synthetic, medicinal chemistry and chemical biology are making to the life and medical sciences now and in the future. Chemistry is playing an increasingly pivotal role and chemists are often intimately involved at the forefront of the biological sciences whilst bringing to them the distinctive approaches of the rigorous chemical sciences. The Symposium will also highlight the key role of chemistry in the discovery and development of new therapeutic agents for human diseases.
Lectures from a distinguished list of world-leading speakers will cover such topics as:

? Sequencing nucleic acids: from chemistry to life sciences and medicine
? Oligonucleotide-based tools for pharmacology and nano-engineering
? The future of kinase drug discovery - challenges and opportunities
? Vaccines as a new paradigm for the treatment of drug addiction
? Fragment-based drug discovery: a decade of thinking small
? Chemical biology of nanomedicines
? Modulation of DNA damage-response pathways in cancer therapy
? The chemical biology of protein splicing
? Molecular design for selective recognition and reaction with RNA
Target identification for biologically relevant small molecules

Invited Speakers (so far):
Shankar Balasubramanian, University of Cambridge, UK
Clifton Barry, NIH, USA
Michael Farmulok, University of Bonn, Germany
Carlos Garcia-Echeverria, Sanofi-Aventis, France
Roger Griffin, University of Newcastle, UK
Harren Jhoti, Astex UK
Kostas Kostarelos, School of Pharmacy, London UK
Tom Muir, Rockefeller University, USA
Shigeki Sasaki, Kyushu University, Japan
Zhang-Jie Shi, Peking University, China
Herbert Waldmann, MPI, Dortmund, Germany
Robert M. Williams, Colorado State University, USA

Visit http://www.tetrahedronsymposiumasia.com/ for full list.